---
layout: post
title: "Generally Accepted Scientific Knowledge in Applications for Drug and Biological Products: Nonclinical Information; Draft Guidance for Industry; Availability"
date: 2026-02-05 18:55:39 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2023-11148
original_published: 2023-05-25 00:00:00 +0000
significance: 8.00
---

# Generally Accepted Scientific Knowledge in Applications for Drug and Biological Products: Nonclinical Information; Draft Guidance for Industry; Availability

**Published:** February 05, 2026 18:55 UTC
**Source:** Federal Register
**Original Published:** May 25, 2023 00:00 UTC
**Document Number:** 2023-11148

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Generally Accepted Scientific Knowledge in Applications for Drug and Biological Products: Nonclinical Information." This draft guidance is intended to assist sponsors in determining whether it may be appropriate to rely on generally accepted scientific knowledge (GASK) to fulfill certain legal and regulatory requirements applicable to the new drug application (NDA) or biologics licensing application (BLA) in question. When final, this guidance will represent the Agency's current thinking on this topic.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2023/05/25/2023-11148/generally-accepted-scientific-knowledge-in-applications-for-drug-and-biological-products-nonclinical)
- API: https://www.federalregister.gov/api/v1/documents/2023-11148

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
